Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Considering Bone Marrow Blasts from Nonerythroid Cellularity Improves the Prognostic Evaluation of MDS in the Context of IPSS-R and Permits a Better Risk Assessment of MDS Patients Classified into the Intermediate Risk Category

Blood (2016) 128 (22): 3185.

https://doi.org/10.1182/blood.V128.22.3185.3185

Published: 2016

Journal Articles

Immunophenotypic Profile and Recurrent Somatic Mutations in 131 Chronic Lymphocytic Leukemia Patients: Low Expression of CD25 in NOTCH1-Mutated Cases

Miriam Castillo, Ana María Hurtado, Tzu Hua Chen-Liang, Julia Muñoz-Ballester, Bartlomiej P Przychodzen, MSc, María Dolores García-Malo, Felipe De Arriba, Francisco José Ortuño, Jaroslaw P. Maciejewski, MD, PhD, FACP, Vicente Vicente, Andres Jerez, MD

Blood (2016) 128 (22): 3201.

https://doi.org/10.1182/blood.V128.22.3201.3201

Published: 2016

Journal Articles

Considering Bone Marrow Blasts from Nonerythroid Cells Improves the Prognostic Evaluation of Myelodysplastic Syndromes with Ring Sideroblasts

Blood (2016) 128 (22): 1991.

https://doi.org/10.1182/blood.V128.22.1991.1991

Published: 2016

Journal Articles

Anticipating High-Risk Chromosome Clonal Evolution in Chronic Lymphocytic Leukemia: A Next Generation Sequencing and Longitudinal FISH Combined Study

Ana Maria Hurtado, Chahinez Hamedi, Bartlomiej P Przychodzen, Ana I. Anton, Maria Dolores Garcia-Malo, Gloria Soler, Felipe De Arriba, Francisco Ortuño, Raul Teruel Montoya, PhD, Jaroslaw P. Maciejewski, MD PhD, Vicente Vicente, MD PhD, Andres Jerez, MD PhD

Blood (2014) 124 (21): 3305.

https://doi.org/10.1182/blood.V124.21.3305.3305

Published: 2014

Journal Articles

Deubiquitnase BAP1 Downregulation in Myeloid Malignances: A New Pathogenic Mechanism, Dominant in Chronic Myelomonocytic Leukemia

Ana Maria Hurtado, Eva Caparrós, Jose Miguel Torregrosa, Ginés Luengo, Mara Toderici, María Eugenia De la Morena, Begoña Muiña, Maria Luisa Lozano, Constant Martinez, Mari Luz Amigo, Felipe De Arriba, Francisco Ortuño, Raul Teruel Montoya, PhD, Francisca Ferrer-Marin, MD, PhD, Vicente Vicente, MD PhD, Andres Jerez, MD PhD

Blood (2014) 124 (21): 5594.

https://doi.org/10.1182/blood.V124.21.5594.5594

Published: 2014

Journal Articles

Multiple STAT3 Mutations In Different Lymphocyte Clones Of Large Granular Lymphocytic Leukemia Patients

Hanna L M Rajala, MD, Thomas Olson, PhD, Sonja Lagström, MSc, Pekka Ellonen, BSc, Syed Arshi Uz Zaman, MSc, Emma I Andersson, MSc, Michael J. Clemente, Andres Jerez, MD, Kimmo Porkka, MD, PhD, Jaroslaw P. Maciejewski, MD, PhD, Thomas P. Loughran, Jr., M.D., Satu Mustjoki, MD, PhD

Blood (2013) 122 (21): 2559.

https://doi.org/10.1182/blood.V122.21.2559.2559

Published: 2013

Journal Articles

Deletion Of Tifab, a Novel Candidate Gene On Chromosome 5q, Results In Hematopoietic Defects By Changing The Dynamic Range Of Innate Immune Pathway Activation

Melinda Varney, PhD, Susanne Christie, Madeline Niederkorn, Jing Fang, MD, PhD, Andres Jerez, MD, PhD, Jaroslaw P. Maciejewski, MD, PhD, FACP, Jun-ichiro Inoue, PhD, Daniel T Starczynowski, PhD

Blood (2013) 122 (21): 102.

https://doi.org/10.1182/blood.V122.21.102.102

Published: 2013

Journal Articles

Whole Exome Sequencing (“mutatome”) Of Deletion 5q

Naoko Hosono, MD, PhD, Hideki Makishima, MD, PhD, Bartlomiej P Przychodzen, PhD, Andres Jerez, MD, Chantana Polprasert, MD, Yuichi Shiraishi, PhD, Kenichi Chiba, PhD, Hiroko Tanaka, BA, Satoru Miyano, PhD, Kenichi Yoshida, MD, Masashi Sanada, MD, PhD, Jacqueline Boultwood, PhD, Alan List, MD, Mikkael A. Sekeres, MD, MS, Seishi Ogawa, MD, PhD, Jaroslaw P. Maciejewski, MD, PhD

Blood (2013) 122 (21): 656.

https://doi.org/10.1182/blood.V122.21.656.656

Published: 2013

Journal Articles

SQSTM1/p62 Is a Necessary Cofactor In MDS/AML With Deletion Of Mir-146a

Jing Fang, MD/PhD, Brenden Barker, BSc, Lyndsey Bolanos, BSc, Xiaona Liu, BSc, Andres Jerez, MD, PhD, Hideki Makishima, MD, PhD, Dinesh S. Rao, M.D., James C. Mulloy, PhD, Jaroslaw P. Maciejewski, MD, PhD, Jose A. Cancelas, M.D. PhD., Daniel T Starczynowski, PhD

Blood (2013) 122 (21): 747.

https://doi.org/10.1182/blood.V122.21.747.747

Published: 2013

Journal Articles

Spliceosomal Gene LUC7L2 Mutation Causes Missplicing and Alteration Of Gene Expression In Myeloid Neoplasms

Naoko Hosono, MD, PhD, Hideki Makishima, MD, PhD, Bartlomiej Przychodzen, Ph.D., Jarnail Singh, PhD, Richard A Padgett, PhD, Mikkael A. Sekeres, MD, MS, Andres Jerez, MD, Kenichi Yoshida, MD, Yuichi Shiraishi, PhD, Satoru Miyano, PhD, Masashi Sanada, MD, PhD, Seishi Ogawa, MD, PhD, Jaroslaw P. Maciejewski, MD, PhD, FACP

Blood (2013) 122 (21): 470.

https://doi.org/10.1182/blood.V122.21.470.470

Published: 2013

Journal Articles

Karyotypic and Genetic Abnormalities Associated with Clonal Evolution in Paroxysmal Nocturnal Hemoglobinuria.

Hideki Makishima, MD, PhD, Kenichi Yoshida, MD, Michael J. Clemente, Masashi Sanada, MD, Yasunobu Nagata, MD, Manuel G. Afable, II, MD, Andres Jerez, MD, Kenichi Chiba, BA, Yuichi Shiraishi, PhD, Satoru Miyano, PhD, Seishi Ogawa, MD, PhD, Jaroslaw P. Maciejewski, MD, PhD

Blood (2012) 120 (21): 2371.

https://doi.org/10.1182/blood.V120.21.2371.2371

Published: 2012

Journal Articles

Mutational Spectrum of Myelodysplastic Syndrome Malignancies Revealed by Whole Exome Sequencing

Inés Gómez-Seguí, MD, Bartlomiej P Przychodzen, Kenichi Yoshida, MD, Matthew Ruffalo, Andres Jerez, MD, PhD, Hideki Makishima, MD, PhD, Satoru Miyano, PhD, Yuichi Shiraishi, Holleh D Husseinzadeh, MD, Edward P Evans, Naoko Hosono, MD, PhD, Kathryn M Guinta, Thomas LaFramboise, PhD, Seishi Ogawa, MD, PhD, Yogen Saunthararajah, MD, Mikkael A. Sekeres, MD, MS, Jaroslaw P. Maciejewski, MD, PhD

Blood (2012) 120 (21): 307.

https://doi.org/10.1182/blood.V120.21.307.307

Published: 2012

Journal Articles

Association of MDM2 G ene Polymorphisms SNP285 and 309 with Myelodysplastic Syndromes (MDS) Susceptibility and Outcome.

Blood (2012) 120 (21): 2823.

https://doi.org/10.1182/blood.V120.21.2823.2823

Published: 2012

Journal Articles

Mutation Screening Associated with Chromosome 7 Abnormalities Using Next Generation Whole Exome Sequencing

Naoko Hosono, MD, PhD, Hideki Makishima, MD, PhD, Andres Jerez, MD, PhD, Ines Gomez-Segui, MD, Bartlomiej Przychodzen, BS, Mikkael A. Sekeres, MD, MS, Satoru Miyano, PhD, Yuichi Shiraishi, PhD, Seishi Ogawa, MD, PhD, Jaroslaw P. Maciejewski, MD, PhD

Blood (2012) 120 (21): 173.

https://doi.org/10.1182/blood.V120.21.173.173

Published: 2012

Journal Articles

Whole Exome Sequencing to Predict Response to Hypomethylating Agents in MDS

Blood (2012) 120 (21): 1698.

https://doi.org/10.1182/blood.V120.21.1698.1698

Published: 2012

Journal Articles

Downstream Consequences of U2AF1 Mutations in MDS Are a Result of a Specific Misplicing Patterns Due to Faulty Recognition of 3'acceptor Splice Site

Bartlomiej P Przychodzen, Hideki Makishima, Andres Jerez, MD, PhD, Richard A Padgett, PhD, Jaroslaw P. Maciejewski, MD, PhD

Blood (2012) 120 (21): 3517.

https://doi.org/10.1182/blood.V120.21.3517.3517

Published: 2012

Journal Articles

Identifying Immunogenetic Features That Distinguish Immune Mediated, Immunosuppression-Sensitive Disease in Aplastic Anemia (AA)

Manuel G. Afable, II, MD, Theresa Guo, MD, Bartlomiej P Przychodzen, Lisa Rybicki, MS, Michael J. Clemente, Andres Jerez, MD, PhD, Holleh D Husseinzadeh, MD;, Edward P Evans, Alan E. Lichtin, MD, Aleksandra Wodnar-Filipowicz, PhD, Mikkael A. Sekeres, MD, MS, Jaroslaw P. Maciejewski, MD, PhD

Blood (2012) 120 (21): 3481.

https://doi.org/10.1182/blood.V120.21.3481.3481

Published: 2012

Journal Articles

Somatic Mutations in Schinzel-Giedion Syndrome Gene SETBP1 Determine Progression in Myeloid Malignancies

Blood (2012) 120 (21): 2.

https://doi.org/10.1182/blood.V120.21.2.2

Published: 2012

Journal Articles

STAT3-Mutations Indicate the Presence of Subclinical Self-Reactive Cytotoxic T Cell Clones in Aplastic Anemia and Myelodysplastic Syndromes

Blood (2012) 120 (21): 646.

https://doi.org/10.1182/blood.V120.21.646.646

Published: 2012

Journal Articles

Haploinsufficiency of Mir-146a in High-Risk Del(5q) MDS/AML Requires an Intrachromosomal Gene Network Involving p62/TRAF6/NF-κB

Jing Fang, MD/PhD, Andres Jerez, MD, PhD, Christopher Rasch, BSc, Lyndsey Bolanos, BSc, Jaroslaw P. Maciejewski, MD, PhD, Daniel T Starczynowski, PhD

Blood (2012) 120 (21): 557.

https://doi.org/10.1182/blood.V120.21.557.557

Published: 2012

NARROW

Considering Bone Marrow Blasts from Nonerythroid Cellularity Improves the Prognostic Evaluation of MDS in the Context of IPSS-R and Permits a Better Risk Assessment of MDS Patients Classified into the Intermediate Risk Category

Immunophenotypic Profile and Recurrent Somatic Mutations in 131 Chronic Lymphocytic Leukemia Patients: Low Expression of CD25 in NOTCH1-Mutated Cases

Considering Bone Marrow Blasts from Nonerythroid Cells Improves the Prognostic Evaluation of Myelodysplastic Syndromes with Ring Sideroblasts

Anticipating High-Risk Chromosome Clonal Evolution in Chronic Lymphocytic Leukemia: A Next Generation Sequencing and Longitudinal FISH Combined Study

Deubiquitnase BAP1 Downregulation in Myeloid Malignances: A New Pathogenic Mechanism, Dominant in Chronic Myelomonocytic Leukemia

Multiple STAT3 Mutations In Different Lymphocyte Clones Of Large Granular Lymphocytic Leukemia Patients

Deletion Of Tifab, a Novel Candidate Gene On Chromosome 5q, Results In Hematopoietic Defects By Changing The Dynamic Range Of Innate Immune Pathway Activation

Whole Exome Sequencing (“mutatome”) Of Deletion 5q

SQSTM1/p62 Is a Necessary Cofactor In MDS/AML With Deletion Of Mir-146a

Spliceosomal Gene LUC7L2 Mutation Causes Missplicing and Alteration Of Gene Expression In Myeloid Neoplasms

Karyotypic and Genetic Abnormalities Associated with Clonal Evolution in Paroxysmal Nocturnal Hemoglobinuria.

Mutational Spectrum of Myelodysplastic Syndrome Malignancies Revealed by Whole Exome Sequencing

Association of MDM2 G ene Polymorphisms SNP285 and 309 with Myelodysplastic Syndromes (MDS) Susceptibility and Outcome.

Mutation Screening Associated with Chromosome 7 Abnormalities Using Next Generation Whole Exome Sequencing

Whole Exome Sequencing to Predict Response to Hypomethylating Agents in MDS

Downstream Consequences of U2AF1 Mutations in MDS Are a Result of a Specific Misplicing Patterns Due to Faulty Recognition of 3'acceptor Splice Site

Identifying Immunogenetic Features That Distinguish Immune Mediated, Immunosuppression-Sensitive Disease in Aplastic Anemia (AA)

Somatic Mutations in Schinzel-Giedion Syndrome Gene SETBP1 Determine Progression in Myeloid Malignancies

STAT3-Mutations Indicate the Presence of Subclinical Self-Reactive Cytotoxic T Cell Clones in Aplastic Anemia and Myelodysplastic Syndromes

Haploinsufficiency of Mir-146a in High-Risk Del(5q) MDS/AML Requires an Intrachromosomal Gene Network Involving p62/TRAF6/NF-κB

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only